No Detail Found!

Is ischaemic modified albumin a marker in osteomyelitis patients?

Author(s)
Cihan Adanas Department of Orthopedics and Traumatology, Van Yuzuncu Yıl University,Tusba Van Turkey
Sezai Ozkan Department of Orthopedics and Traumatology, Van Yuzuncu Yıl University, Tusba Van Turkey
Canan Demir Health Services Vocational High School, Yuzuncu Yil University, Tusba, Van, Turkey.
Abstract
Objective: To compare the levels of ischaemia modifi ed albumin between osteomyelitis patients and healthy controls. Method: The cross-sectional prospective study was conducted at Van Yüzüncü Yil University, Van, Turkey, from May 2018 to May 2019, and comprised inpatients diagnosed with osteomyelitis, and healthy controls. Serum IMA concentrations were determined spectrophotometrically at 470nm wavelength. Serum ischaemia modifi ed albumin levels were measured and compared between the patients and the controls. Data was analysed using SPSS 20. Results: Of the 77 subjects, 37(48%) were patients and 40(52%) were controls. Serum ischaemia modifi ed albumin level in patients was signifi cantly higher than controls (p<0.05). There was a signifi cant correlation between ischaemia modifi ed albumin and C-reactive protein levels (p<0.05). Conclusion: Serum ischaemia modifi ed albumin level in patients was signifi cantly higher than controls (p<0.05).
Publication Details
Page(s) 461-464
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 71, Issue: 2A, Year: 2021

Request the full text from PASTIC

Keywords
C-reactive protein, Biomarker, Ischaemia-modified albumin, Receiving operation curve, :Osteomiyelitis
0

Citations

0

Downloads

49

Views